SCHEMBL563900

SCHEMBL563900

CCOP(=O)(O)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26091818 0.97 TSHR (0.48)
SCHEMBL20543358 0.84 PPARD (0.38)
SCHEMBL3121986 0.80 TSHR (0.48)
SCHEMBL9539864 0.78
SCHEMBL20543363 0.78 TSHR (0.41)
Diethyl Hydrogen Phosphate SCHEMBL27641870 0.77 TSHR (0.50)
SCHEMBL575446 0.75
SCHEMBL40792 0.75
SCHEMBL575807 0.75
Diethyl Hydrogen Phosphate SCHEMBL93056 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102522590-B Non-aqueous organic electrolyte, lithium ion secondary battery containing non-aqueous organic electrolyte, preparation method of lithium ion secondary battery and terminal communication equipment HUAWEI TECH CO LTD 2014-09-17 CN claimed
CN-102522590-A Non-aqueous organic electrolyte, lithium ion secondary battery containing non-aqueous organic electrolyte, preparation method of lithium ion secondary battery and terminal communication equipment HUAWEI TECH CO LTD 2012-06-27 CN claimed
US-20250092067-A1 APT1 and APT2 Inhibitors and Uses Thereof CORNELL UNIVERSITY 2025-03-20 US disclosed
US-12191448-B2 Nonaqueous electrolyte solution for secondary battery, and secondary battery provided with said solution STELLA CHEMIFA CORPORATION (JP) 2025-01-07 US disclosed
CN-116003486-B Lead compound, preparation method thereof and application thereof in preparation of anti-influenza virus drugs 北京天之泰生物科技有限公司 2023-08-01 CN disclosed
CN-111433962-B Electrolyte for nonaqueous electrolyte battery and nonaqueous electrolyte battery using same 中央硝子株式会社 2023-07-14 CN disclosed
WO-2023066404-A1 DISUBSTITUTED DIHALOGEN PHOSPHATE ADDITIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF 山东海科创新研究院有限公司 2023-04-27 WO disclosed
CN-116003486-A Lead compound, preparation method thereof and application thereof in preparation of anti-influenza virus drugs 北京天之泰生物科技有限公司 2023-04-25 CN disclosed
WO-2022246115-A1 APT1 AND APT2 INHIBITORS AND USES THEREOF CORNELL UNIVERSITY (US) 2022-11-24 WO disclosed
CN-114728992-A Method for producing phosphate compound 斯泰拉化工公司 2022-07-08 CN disclosed
CN-108475822-B Nonaqueous electrolyte solution for secondary battery and secondary battery provided with same 斯泰拉化工公司 2022-03-11 CN disclosed
EP-1541590-A1 Process for the oxidation of hydroxy compounds by means of nitroxy compounds SCA Hygiene Products AB (SE) 2005-06-15 EP disclosed
EP-1541552-A1 Process for the recovery of nitroxy compounds from organic solutions and oxidation process SCA Hygiene Products AB (SE) 2005-06-15 EP disclosed
EP-1541565-A1 Process for the separation of organic nitrosonium and/or hydroxylamine compounds by means of cation exchange resins and recovery and oxidation processes based thereon SCA Hygiene Products AB (SE) 2005-06-15 EP disclosed
US-20050121159-A1 Process for the oxidation of hydroxy compounds by means of nitroxy compounds SCA HYGIENE PRODUCTS AB (SE) 2005-06-09 US disclosed
US-20050121160-A1 Process for the separation of organic nitrosonium and/or hydroxylamine compounds by means of cation exchange resins and recovery and oxidation processes based thereon SCA HYGIENE PRODUCTS AB (SE) 2005-06-09 US disclosed
US-6617337-B1 Administering to said patient a blood pressure lowering effective amount of a nitroxide selected from the group consisting of TEMPO, DOXYL and PROXYL. GEORGETOWN UNIVERSITY 2003-09-09 US disclosed
WO-2002026231-A1 USE OF NITROXIDES FOR THE TREATMENT OF VASCULAR DISORDERS IN A DIABETIC MAMMAL GEORGETOWN UNIVERSITY (US) 2002-04-04 WO disclosed
EP-1014980-A1 USE OF NITROXIDES FOR THE TREATMENT OF ESSENTIAL HYPERTENSION Georgetown University (US) 2000-07-05 EP disclosed
WO-1999013875-A1 USE OF NITROXIDES FOR THE TREATMENT OF ESSENTIAL HYPERTENSION GEORGETOWN UNIVERSITY MEDICAL CENTER (US) 1999-03-25 WO disclosed